CATX Perspective Therapeutics
Perspective Therapeutics earnings company data as of 4:48 AM ET 10/23
Limited consensus data for this ticker (thin coverage or data-plan limits).
Dates may be company-announced rather than sell-side consensus.
Calendar and recent prints remain the primary lens when available.
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 9 Nov | EPS | — | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by CATX's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $42K bought by 2 insiders
- $1.6M sold by 2 insiders outside a trading plan
- None no planned (10b5-1) sales
-
Lantheus Alpha Therapy, LLC 10% owner, +1 joint filerSale$777K 247,932 shares at $3.13 2.2% of stakeTraded Sep 3–4 Filed Sep 8
-
Lantheus Alpha Therapy, LLC 10% owner, +1 joint filerSale$131K 42,129 shares at $3.11 0.4% of stakeTraded Sep 2 Filed Sep 4
-
Lantheus Alpha Therapy, LLC 10% ownerSale$357K 113,914 shares at $3.14 1% of stakeTraded Aug 31–Sep 1 Filed Sep 4
-
Lantheus Holdings, Inc. 10% ownerSale$112K 35,769 shares at $3.12 0.3% of stakeTraded Sep 1 Filed Sep 3
-
Lantheus Holdings, Inc. 10% ownerSale$246K 78,145 shares at $3.14 0.7% of stakeTraded Aug 31 Filed Sep 2
-
Jonathan Robert Hunt Chief Accounting OfficerBuy$22K 11,000 shares at $2.03 +23% to stakeTraded Nov 13, 2025 Filed Nov 17, 2025
-
Robert F Williamson III DirectorBuy$20K 9,498 shares at $2.10 +2595% to stakeTraded Nov 12, 2025 Filed Nov 14, 2025
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,8.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,8.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,8.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.